Vice President of Product Management, Clinical Next Generation Sequencing, Thermo Fisher Scientific
BIOGRAPHY
Speaker
Abstract
Overview of Genexus, current assays & benefits of using the platform post-COVID (minimal hands-on time, reduced/furloughed lab staff). See if he can bring in customer perspective or testimonials, Q&A.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...